Trexquant Investment LP Deciphera Pharmaceuticals, Inc. Transaction History

Trexquant Investment LP

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$13.58 - $17.36 $661,862 - $846,091	-48,738 Reduced 35.84%	87,256 $1.37 Million
Q4 2023 Feb 09, 2024	BUY	$10.11 - $16.54 $1.37 Million - $2.25 Million	135,994 New	135,994 $2.19 Million
Q2 2023 Aug 11, 2023	SELL	$13.28 - $15.96 $319,623 - $384,125	-24,068 Reduced 39.8%	36,402 $512,000
Q1 2023 May 15, 2023	BUY	$14.26 - $22.1 $536,960 - $832,175	37,655 Added 165.04%	60,470 $934,000
Q4 2022 Feb 13, 2023	SELL	$14.85 - $19.04 $123,596 - $158,469	-8,323 Reduced 26.73%	22,815 $373,000
Q3 2022 Nov 14, 2022	BUY	$12.38 - $20.23 $385,488 - $629,921	31,138 New	31,138 $576,000
Q1 2022 May 13, 2022	SELL	$6.87 - $11.11 $98,234 - $158,861	-14,299 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$7.7 - $37.13 $110,102 - $530,921	14,299 New	14,299 $140,000
Q2 2020 Aug 07, 2020	SELL	$37.05 - $65.03 $1.1 Million - $1.93 Million	-29,634 Closed	0 $0
Q1 2020 May 08, 2020	BUY	$33.63 - $69.4 $723,145 - $1.49 Million	21,503 Added 264.46%	29,634 $1.22 Million
Q4 2019 Feb 12, 2020	BUY	$31.7 - $69.93 $17,054 - $37,622	538 Added 7.09%	8,131 $506,000
Q3 2019 Nov 08, 2019	BUY	$19.95 - $38.85 $151,480 - $294,988	7,593 New	7,593 $258,000
Q2 2019 Aug 09, 2019	SELL	$21.05 - $26.21 $372,753 - $464,126	-17,708 Closed	0 $0
Q1 2019 May 13, 2019	BUY	$20.65 - $29.55 $365,670 - $523,271	17,708 New	17,708 $411,000
Q3 2018 Nov 09, 2018	SELL	$33.57 - $42.1 $172,986 - $216,941	-5,153 Closed	0 $0
Q2 2018 Aug 07, 2018	BUY	$20.06 - $44.95 $103,369 - $231,627	5,153 New	5,153 $203,000

293K

500

Ticker DCPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,822,100
Description
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

Stay updated on Trexquant Investment LP with notifications on news.